Literature DB >> 6123130

Dose dependent changes in propranolol half life when used as an adjunct to neuroleptic treatment.

D H Staniforth, N J Yorkston, S A Zaki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123130     DOI: 10.1007/bf00430757

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  17 in total

1.  Inhibition of propranolol metabolism by chlorpromazine.

Authors:  R E Vestal; D M Kornhauser; J W Hollifield; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

2.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

3.  The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Preliminary clinical observations.

Authors:  A Atsmon; I Blum; H Wijsenbeek; B Maoz; M Steiner; G Ziegelman
Journal:  Psychiatr Neurol Neurochir       Date:  1970 May-Jun

4.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion.

Authors:  A Atsmon; I Blum; M Steiner; A Latz; H Wijsenbeek
Journal:  Psychopharmacologia       Date:  1972

6.  Metabolism of propranolol by rat liver microsomes and its inhibition by phenothiazine and tricyclic antidepressant drugs.

Authors:  D G Shand; J A Oates
Journal:  Biochem Pharmacol       Date:  1971-07       Impact factor: 5.858

7.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

8.  Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

9.  Safeguards in the treatment of schizophrenia with propranolol.

Authors:  N J Yorkston; S A Zaki; J F Themen; C W Havard
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

10.  Propranolol in the control of schizophrenic symptoms.

Authors:  N J Yorkston; S A Zaki; M K Malik; R C Morrison; C W Havard
Journal:  Br Med J       Date:  1974-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.